CV3- VASOPEPTIDASE INHIBITOR REDUCES IN-HOSPITAL COSTS FOR CONGESTIVE HEART FAILURE PATIENTS- RESULTS FROM THE IMPRESS TRIAL
Sep 1, 2001, 00:00
10.1016/S1098-3015(11)71495-4
https://www.valueinhealthjournal.com/article/S1098-3015(11)71495-4/fulltext
Title :
CV3- VASOPEPTIDASE INHIBITOR REDUCES IN-HOSPITAL COSTS FOR CONGESTIVE HEART FAILURE PATIENTS- RESULTS FROM THE IMPRESS TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71495-4&doi=10.1016/S1098-3015(11)71495-4
First page :
Section Title :
Open access? :
No
Section Order :
9